4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18555467 | COCRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR | RAHMANI, NILOOFAR | 1691 | Non-Final OA | Oct 13, 2023 |
| 18043971 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE | SEAMAN, D MARGARET M | 1625 | Non-Final OA | Mar 03, 2023 |
| 18041617 | OSIMERTINIB AND SELPERCATINIB COMBINATIONS FOR THE TREATMENT OF EGFR- AND RET-ASSOCIATED CANCERS | BURKETT, DANIEL JOHN | 1624 | Non-Final OA | Feb 14, 2023 |
| 17996028 | CRYSTALLINE RET INHIBITOR | MARTIN, KEVIN STEPHEN | 1624 | Final Rejection | Oct 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial